Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
Clinical trial NCT05323110 · TERMINATED
Trial details
- NCT number
- NCT05323110
- Sponsor
- Capella Bioscience Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2023-08-22
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.